48-week data from MOMENTUM phase III clinical trial show momelotinib maintained total symptom response
The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022
The plant, to be built in the Incheon Free Economic Zone in Songdo, Incheon, will be a facility for the manufacture of products such as sterile bags, cell culture media and membrane filters
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Aster DM Healthcare and Faruk Medical City will jointly provide training and academic support to medical and paramedical staff
The proceeds of the issue has been/will be reinvested in the company and to meet its own business requirements.
More women centric initiatives being the need of the hour for holistic development
The IPO is a complete OFS by existing shareholder Helix Investment Holdings
Proceeds from the transaction will be reinvested towards the growth, innovation and expansion of Healthium’s advanced surgery, orthopaedics, wound care and post-surgical care portfolio
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Subscribe To Our Newsletter & Stay Updated
